TSCAN THERAPEUTICS, INC. Retained Earnings
TSCAN THERAPEUTICS, INC. (TCRX) had Retained Earnings of -$563.89 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-12
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$563.89M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$533.53M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$504.86M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$481.88M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$563.89M 10-Q · filed 2026-08-12 |
| 2026-03-31 | -$533.53M 10-Q · filed 2026-05-06 |
| 2025-12-31 | -$504.86M 10-Q · filed 2026-08-12 |
| 2025-09-30 | -$481.88M 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$446.18M 10-Q · filed 2025-08-12 |
| 2025-03-31 | -$409.22M 10-Q · filed 2025-05-06 |
| 2024-12-31 | -$375.10M 10-K · filed 2026-03-04 |
| 2024-09-30 | -$339.29M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$309.40M 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$277.74M 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$247.60M 10-K · filed 2025-03-05 |
| 2023-09-30 | -$227.98M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$204.99M 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$180.94M 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$158.38M 10-K · filed 2024-03-06 |
| 2022-09-30 | -$139.66M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$123.41M 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$108.31M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$92.16M 10-K · filed 2023-03-08 |
| 2021-09-30 | -$77.96M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$62.12M 10-Q · filed 2021-08-19 |
| 2020-12-31 | -$43.53M 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |